Jeffrey W. Sherman, Director of Larimar Therapeutics LRMR, has filed 2 purchases and 4 sales on the open market. Over the past 12 months that comes to a net purchase of $25K. The latest trade was on 05/19.

JS

JS

Jeffrey W. Sherman

Director

Company

Larimar Therapeutics LRMR

First filing

23/01/04

Trades

49 trades

Buys / sales

2 / 4

12-month net buying

$25K

Last trade

05/19

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Larimar TherapeuticsLRMR	Open-market buy	02/27	03/02	5,000 sh	$5.00	$25,000	No record
Xeris Biopharma HoldingsXERS	Open-market sale	25/08/28	25/08/29	42,232 sh	$7.92	$334,477.44	−16.2%
Xeris Biopharma HoldingsXERS	Open-market buy	23/11/27	23/11/29	5,400 sh	$1.87	$10,098	No record
HP Horizon Therapeutics Public	Open-market sale	23/01/10–23/01/11	23/01/12	6,736 sh2 trades	$113.07avg.	$761,673.2	−15.7%
HP Horizon Therapeutics Public	Open-market sale	23/01/06	23/01/06	5,187 sh	$113.29	$587,635.23	−9.5%